Medical Systems Advanced Development
Abstract
This Program Element (PE) funds development of medical materiel within the early system integration portion of the System Development and Demonstration phase of the acquisition life cycle using 6.4 (Advanced Component Development and Prototype) funding. Program efforts support transition of promising Science and Technology candidate medical technologies (drugs, vaccines, medical devices, diagnostics, and mechanisms for detection and control of disease carrying insects) to larger scale testing in humans for safety and effectiveness. Programs are aligned to meet future force requirements identified within concept documents and organizational structures. This PE also provides funding for Food and Drug Administration (FDA) regulated human clinical trials to gain additional information about safety and effectiveness on the path to licensure for use in humans. The Projects supported by this PE are: Project 808 funds development of candidate medical countermeasures for infectious diseases of military relevance. Efforts include vaccines, drugs, diagnostic kits/devices, and insect control measures. These funds support human clinical efficacy trials of the drug/vaccine in a larger group that are designed to assess performance and to continue safety assessments in a larger group of volunteers. Products from this Project will transition to PE 0604807A/Project 849. Project 811 funds the development of military relevant human immunodeficiency virus (HIV) medical countermeasures. It provides funding for planning and conducting of human clinical trials in a group of healthy volunteers to assess the drug/vaccine for safety, tolerability, how the drug/vaccine is distributed, metabolized, and excreted from the body, and investigate the appropriate dose for therapeutic use. Products from this Project will transition to PE 0604807A/Project 812. Project 836 funds the demonstration and validation of medical products for enhanced combat casualty care and follow-on care, including rehabilitation. This project also funds the human clinical trials that test the safety and effectiveness of biologics, devices and demonstration. Clinical trials are conducted in accordance with United States (U.S.) FDA regulations. Products from this project will transition to PE 0604807A/Project 832. Project VS7 funds program upgrades, retrofits, trains, and sustains the fleet of Medical Evacuation legacy helicopters that continue to play a major role in Iraq and Afghanistan. The approved force design increased the number of air frames in the force from 12 to 15 aircraft for 37 medical evacuation (MEDEVAC) companies. All products from this Project will transition to PE 0604807A/Project VS8. Project CS4 funds congressionally special interest in:Transport Telemedicine - Initiate Joint Advanced Technology Demonstration to provide Medical Treatment Facility (MTF) automatic situational awareness system to identify patients en-route to MTFs and automate paramedic tasks. These Projects are managed by U.S. Army Medical Materiel Development Activity (USAMMDA) and U.S. Army Medical Materiel Agency (USAMMA) of the U.S. Army Medical Research and Materiel Command. Project FF4 funded Secretary of Defense approved counterdrug advanced development efforts used in a major re-design of the Forensic Toxicology Drug Testing Laboratory (FTDTL) information management system used to test urine samples for the presence of illegal drugs. The Drug Testing Program - Client Collection System (DTP-CSS) is comprised of several variations of a desktop application used to select service members for random drug testing, prepare labels for urine specimen bottles, and print corresponding chain-of-custody documents. This Project will standardize DTP-CSS across all services and migrate it to a Web-based system.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2019
- Source ID
- 0603807A_4_2040_PB_2019
- Change Summary Explanation
- In Fiscal Year 2017 there was a Congressional Add of $7.5 Million for Medical Systems Advanced Development Initiatives, an Office of the Secretary of Defense (OSD)-directed $4.0 Million transfer to Project FF4, counterdrug DVR System Development and Demonstration, and there was a reprogramming action of $3.506 Million from 0604807A/812 to 0603807A/811 for HIV Vaccine Development.
- Service Agency Name
- Army
Entities
Organizations
- United States Army
Related Documents
- Child Project: DoD Drug & Vacc Ad
- Child Accomplishment: DoD Drug and Vaccine Advanced Development
- Child Cost Item: 015ce9f8f1f831ec4592031a412b719f
- Child Cost Item: 459d6a3d966bf021184aa1a9450ad9f6
- Child Cost Item: 462adffdd8de2c34f14291ea260ba70d
- Child Cost Item: 197fce647a56c5cba234a45b991cc95a
- Child Cost Item: 79e08733b2bf38be3bc5acae9df5043c
- Child Cost Item: 8f5307cb890933853c7a5e407b320666
- Child Cost Item: 9f2c49403a8848c333c88177eb5f93ef
- Child Cost Item: 92a06d81f2427ae0b881a6dbfd7ae5b7
- Child Project: Mil HIV Vac&Drug Dev
- Child Accomplishment: Military HIV Vaccine & Drug Development
- Child Cost Item: 3f141afeb5b247f16ec68fec98c1a137
- Child Cost Item: de1661e846448fa18c74948790bb46a2
- Child Cost Item: 188d2cf8995e49930c73423aa000b264
- Child Cost Item: 7c220f842a264442305e1c8414a509c8
- Child Project: Field Medical Systems Advanced Development
- Child Accomplishment: Field Medical Systems Advanced Development - Program Management (PM) Medical Devices
- Child Accomplishment: Field Medical Systems Advanced Development - PM Medical Support Systems
- Child Accomplishment: Field Medical Systems Advanced Development - PM Tissue Injury and Regenerative Medicine
- Child Accomplishment: Field Medical Systems Advanced Development - PM Pharmaceutical Systems
- Child Cost Item: 290a5fdf177c6a51cc607374f5731351
- Child Cost Item: 968c17d99707141115d75cb0bdec6f93
- Child Cost Item: 9357eec17a1c269ab197164c3120a6b2
- Child Cost Item: 278148bf6ca04691251bc42378455f9e
- Child Cost Item: 89a48b67e6930db1ea565be935ae7aab
- Child Cost Item: f102010d7891e168830d3749fb252da7
- Child Cost Item: 7eab87485ed28fb61163e6bb83a9c055
- Child Cost Item: eebed4696b5ef638bf06d44fe13bb89b
- Child Cost Item: 1a6a489b8c539e47c50a67ce764b7cb2
- Child Cost Item: 7818a3d17e7eb632619fcd6f8180af25
- Child Cost Item: 4b6d32b58b1e723116c2823c50815f41
- Child Cost Item: 0ecf6e82bcdcd34234892f0260c3ef49
- Child Cost Item: b1800bf45584e24e81b19ab2401ce023
- Child Cost Item: 6996974cefc90b20bfd25a1df33abca3
- Child Cost Item: 235316d4629625f712ae4d6a0792206b
- Child Cost Item: 273ac62319ad82f19517b1ed6f6746f4
- Child Cost Item: 6add7c399e0db43694591b6504d90e29
- Child Cost Item: e63e89c7f601dd1652db1957936270a3
- Child Cost Item: dfa6a272c9e329d6cc9570fb21d0b858
- Child Cost Item: 6e434f6f24a1a394426c07c01d18a61c
- Child Cost Item: 03a2d623aa134a209f14d0aea23c5bb1
- Child Cost Item: 137603a4b0a337b6c06bcc235e061af5
- Child Project: MEDICAL SYSTEMS ADV DEV INITIATIVES (CA)
- Child Cost Item: f068a60bb48394730c4a04ecc8bf7aef
- Child Project: Counterdrug, DDR, Sys Development & Demonstration
- Child Accomplishment: Development and demonstration of tracking laboratory urine samples used in drug testing
- Child Cost Item: 61339ee88008711b867c0e163f665a85
- Child Project: MEDEVAC Mission Equipment Package (MEP) - Adv Dev
- Child Accomplishment: Medical Evacuation Development
- Child Cost Item: 15f918e3316efd6529d39eae8e393003
- Child Cost Item: d1b7e758379459e04ce11732caa15cc4
- Child Cost Item: 136b4640e42128c32d3c229e3a026ea6
- Child Cost Item: fc13079c20bdd9507a932c423680486e